Question 1

What is CaliciX™ Max used for?

Accepted Answer

CaliciX™ Max is a high-strength systemic antiviral capsule formulated for cats suffering from severe, refractory, or high-viral-load feline calicivirus (FCV) disease, where standard-dose therapy may be insufficient.

Question 2

How is CaliciX™ Max different from CaliciX™?

Accepted Answer

CaliciX™ Max delivers 30 mg of EIDD-1931 per capsule, enabling veterinarians to achieve higher systemic antiviral suppression with fewer capsules compared to CaliciX™.

It is intended for step-up therapy in advanced, severe, or poorly responsive feline calicivirus (FCV) cases.

Question 3

When should CaliciX™ Max be considered for FCV therapy?

Accepted Answer

CaliciX™ Max may be considered under veterinary supervision when a cat has:

• Severe oral or oropharyngeal disease
 • Refractory FCGS or post-extraction stomatitis
 • High systemic viral burden
 • Poor response to 2-4mg/kg dosing
 • Larger body weight requiring higher per-dose exposure

Question 4

What FCV-associated conditions is CaliciX™ Max designed to support?

Accepted Answer

CaliciX™ Max is formulated to support cats with severe FCV-associated disease, including:

• Severe feline chronic gingivostomatitis (FCGS)
 • Caudal stomatitis with extensive inflammation
 • Deep lingual ulceration (viral glossitis)
 • Multifocal oral ulceration
 • Virulent systemic feline calicivirus (VS-FCV)

Question 5

Can CaliciX™ Max help cats with virulent systemic calicivirus (VS-FCV)?

Accepted Answer

Yes, CaliciX™ Max is designed for veterinarian-directed use in such severe presentations, alongside intensive supportive care.

Question 6

Is CaliciX™ Max an antibiotic?

Accepted Answer

No. CaliciX™ Max is not an antibiotic. It is a direct-acting antiviral designed to suppress FCV viral replication. Antibiotics may still be used separately to manage secondary bacterial infections when indicated.

Question 7

How does EIDD-1931 work in severe FCV disease?

Accepted Answer

EIDD-1931 interferes with viral RNA replication by inducing lethal mutagenesis in RNA viruses. This mechanism:

• Does not rely on viral proteases
 • Has a high genetic barrier to resistance
 • Works independently of host immune status

Question 8

Is CaliciX™ Max suitable for long-term use?

Accepted Answer

CaliciX™ Max may be used as part of an extended management plan in cats with chronic or refractory feline calicivirus (FCV) where ongoing antiviral control is clinically indicated.

Treatment duration, dose adjustments, and monitoring should always be determined by a licensed veterinarian based on the individual patient’s response and overall health status.

Question 9

Can CaliciX™ Max replace dental extraction or supportive care?

Accepted Answer

No. CaliciX™ Max is intended to be part of a comprehensive veterinary treatment plan, which may include dental procedures, pain control, nutritional support, and other therapies as needed.

Question 10

Is CaliciX™ Max the same as human molnupiravir?

Accepted Answer

No. CaliciX™ Max is not the same as human molnupiravir.

It contains EIDD-1931, the active antiviral metabolite of molnupiravir—the form that directly exerts antiviral activity. Published research indicates that EIDD-1931 demonstrates significantly higher antiviral potency than molnupiravir, which is a prodrug requiring metabolic conversion.

CaliciX™ Max is formulated specifically for veterinary use in cats, with dosing, capsule size, and clinical intent designed for feline patients rather than humans.

Question 11

Is CaliciX™ Max safe for all cats?

Accepted Answer

It may not be suitable for:
 • Pregnant or breeding cats
 • Cats with significant hepatic or renal disease

CaliciX™ Max is intended for veterinary-supervised use only.

Question 12

Why does CaliciX™ Max come in a 30 mg strength?

Accepted Answer

The 30 mg strength allows veterinarians to:
 • Achieve higher antiviral exposure
 • Reduce capsule burden in large or severe cases
 • Improve dosing accuracy and compliance

This makes it suitable for advanced or high-risk FCV disease.

Question 13

Do I need to consult veterinarians before using CaliciX™ Max?

Accepted Answer

Yes. CaliciX™ Max is intended for off-label veterinary use under professional supervision, with informed owner consent.

MolnuFIP™

Effective FIP Treatment at an Affordable Price.

CaliciX™ & CaliciX™ Max

Effective Feline Calicivirus (FCV) Treatment.

Recovery in 4 to 8 Weeks

87% Success Rate

Zero Injections, easy at home treatment

Substantially higher antiviral potency than Molnupiravir (EIDD-2801)

Rapid reduction of FCV replication

long-term management of calicivirus

"EIDD-1931 is not suitable for all FIP conditions. Cats with neurologic and ocular FIP symptoms, appetite and digestive problems, and pre-existing kidney and liver diseases should start FIP treatment with GS-441524 injections for 2 - 4 weeks before switching to EIDD-1931."